Getein Biotech, Inc (SHA:603387)
China · Delayed Price · Currency is CNY 8.75
0.00 (0.00%)
At close: Jan 23, 2026
Getein Biotech Company Description
Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally.
The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, and other fields, such as such as myocardium, inflammation, renal function, thyroid function, hormones, glucose metabolism, tumor, coagulation, blood cells detection.
The company was founded in 2002 and is headquartered in Nanjing, China.
Getein Biotech, Inc
| Country | China |
| Founded | 2002 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,947 |
| CEO | Enben Su |
Contact Details
Address: No.9 Bofu Road Nanjing, 211505 China | |
| Phone | 86 25 6856 8588 |
| Website | getein.com.cn |
Stock Details
| Ticker Symbol | 603387 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002RR9 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Enben Su | Chairman and GM |
| Wen Ni | Accounting Supervisor, Financial Director and Director |
| Tingting Kong | Deputy GM and Director |
| Bin Yan | Deputy GM and Director |
| Cong Liu | Secretary of the Board of Directors |